相似文献
1
Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.1型糖尿病在理解自身免疫性疾病自然史及预防方面的经验教训。
Rheum Dis Clin North Am. 2014 Nov;40(4):797-811. doi: 10.1016/j.rdc.2014.07.008. Epub 2014 Sep 2.
2
Prevention versus intervention of type 1 diabetes.1 型糖尿病的预防与干预。
Clin Immunol. 2013 Dec;149(3):332-8. doi: 10.1016/j.clim.2013.05.018. Epub 2013 Jun 10.
3
Primary and secondary prevention of Type 1 diabetes.1 型糖尿病的一级和二级预防。
Diabet Med. 2013 Feb;30(2):161-9. doi: 10.1111/dme.12100.
4
Immunotherapies in diabetes mellitus type 1.1 型糖尿病的免疫疗法。
Med Clin North Am. 2012 May;96(3):621-34, xi. doi: 10.1016/j.mcna.2012.04.008. Epub 2012 May 24.
5
Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.1 型糖尿病的免疫疗法试验：乔治·艾森巴思的贡献。
Diabetes Technol Ther. 2013 Jun;15 Suppl 2(Suppl 2):S2-13-S2-20. doi: 10.1089/dia.2013.0107.
6
Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes.1A型糖尿病的免疫发病机制及免疫治疗方法
Expert Opin Biol Ther. 2004 Oct;4(10):1569-75. doi: 10.1517/14712598.4.10.1569.
7
Preventing type 1 diabetes in childhood.预防儿童 1 型糖尿病。
Science. 2021 Jul 30;373(6554):506-510. doi: 10.1126/science.abi4742.
8
[Prediction and prevention of type 1 diabetes mellitus: initial results and recent prospects].[1型糖尿病的预测与预防：初步结果及近期展望]
Orv Hetil. 2011 Nov 27;152(48):1916-21. doi: 10.1556/OH.2011.29246.
9
Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes.预防、改善和治愈1型糖尿病的免疫治疗方法。
Am J Ther. 2005 Nov-Dec;12(6):481-90. doi: 10.1097/01.mjt.0000178782.97413.79.
10
Strategies to prevent type 1 diabetes.预防 1 型糖尿病的策略。
Diabetes Obes Metab. 2009 Oct;11(10):931-8. doi: 10.1111/j.1463-1326.2009.01064.x. Epub 2009 May 19.
引用本文的文献
1
Neutrophil-Associated Inflammatory Changes in the Pre-Diabetic Pancreas of Early-Age NOD Mice.早发 NOD 小鼠糖尿病前期胰腺中中性粒细胞相关炎症变化。
Front Endocrinol (Lausanne). 2021 Mar 10;12:565981. doi: 10.3389/fendo.2021.565981. eCollection 2021.
2
The Diabetes Syndrome - A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms.糖尿病综合征——一组具有共同、相互关联病理生理机制的病症。
Int J Gen Med. 2021 Mar 18;14:923-936. doi: 10.2147/IJGM.S305156. eCollection 2021.
3
Is It Time to Screen the General Population for Type 1 Diabetes?是时候对普通人群进行1型糖尿病筛查了吗？
US Endocrinol. 2015;11(1):10-6. doi: 10.17925/use.2015.11.1.10. Epub 2015 Apr 24.
4
Remission of autoimmune diabetes by anti-TCR combination therapies with anti-IL-17A or/and anti-IL-6 in the IDDM rat model of type 1 diabetes.抗 TCR 联合疗法联合抗 IL-17A 或/和抗 IL-6 治疗 1 型糖尿病 IDDM 大鼠模型的自身免疫性糖尿病缓解。
BMC Med. 2020 Feb 28;18(1):33. doi: 10.1186/s12916-020-1503-6.
5
Population-based estimates of humoral autoimmunity from the U.S. National Health and Nutrition Examination Surveys, 1960-2014.基于美国国家健康和营养调查（1960-2014 年）的人群体液自身免疫估计。
PLoS One. 2020 Jan 13;15(1):e0226516. doi: 10.1371/journal.pone.0226516. eCollection 2020.
6
Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.调节性 T 细胞可塑性和稳定性与自身免疫性疾病。
Clin Rev Allergy Immunol. 2020 Feb;58(1):52-70. doi: 10.1007/s12016-018-8721-0.
7
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.聚腺苷二磷酸核糖聚合酶抑制剂在非肿瘤性疾病治疗中的再利用机会。
Br J Pharmacol. 2018 Jan;175(2):192-222. doi: 10.1111/bph.13748. Epub 2017 Mar 26.
8
Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution.1型糖尿病发生与发展过程中的饮食、微生物群与免疫系统
Nutrients. 2015 Nov 6;7(11):9171-84. doi: 10.3390/nu7115461.
9
Towards an Earlier and Timely Diagnosis of Type 1 Diabetes: Is it Time to Change Criteria to Define Disease Onset?迈向1型糖尿病的早期及时诊断：是时候改变定义疾病发病的标准了吗？
Curr Diab Rep. 2015 Dec;15(12):115. doi: 10.1007/s11892-015-0690-6.
10
New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.预测T细胞介导的药物反应的新方法：诱导性和潜在可预防的自身免疫的作用。
J Allergy Clin Immunol. 2015 Aug;136(2):252-7. doi: 10.1016/j.jaci.2015.06.024.
本文引用的文献
1
The artificial pancreas: current status and future prospects in the management of diabetes.人工胰腺：糖尿病管理中的现状和未来前景。
Ann N Y Acad Sci. 2014 Apr;1311:102-23. doi: 10.1111/nyas.12431.
2
Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review.用于预测1型糖尿病的既定和新兴生物标志物：一项系统综述。
Transl Res. 2014 Aug;164(2):110-21. doi: 10.1016/j.trsl.2014.02.004. Epub 2014 Mar 4.
3
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE.风湿性疾病的发病机制与防治：以临床前 RA 和 SLE 为重点。
Nat Rev Rheumatol. 2014 Apr;10(4):212-28. doi: 10.1038/nrrheum.2014.6. Epub 2014 Feb 11.
4
The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings.青少年糖尿病研究基金会伴有糖尿病的胰腺器官捐赠者网络（nPOD）计划：目标、运作模式和新发现。
Pediatr Diabetes. 2014 Feb;15(1):1-9. doi: 10.1111/pedi.12097. Epub 2013 Dec 10.
5
Type 1 diabetes.1 型糖尿病。
Lancet. 2014 Jan 4;383(9911):69-82. doi: 10.1016/S0140-6736(13)60591-7. Epub 2013 Jul 26.
6
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.多种胰岛自身抗体的血清转化与儿童糖尿病进展的风险。
JAMA. 2013 Jun 19;309(23):2473-9. doi: 10.1001/jama.2013.6285.
7
Therapies for active rheumatoid arthritis after methotrexate failure.甲氨蝶呤治疗失败后的活动性类风湿关节炎治疗方法。
N Engl J Med. 2013 Jul 25;369(4):307-18. doi: 10.1056/NEJMoa1303006. Epub 2013 Jun 11.
8
Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.无类风湿关节炎的亲属对与关节炎相关特征有关的抗瓜氨酸化蛋白/肽抗体有反应：类风湿关节炎病因学研究
Arthritis Rheum. 2013 Aug;65(8):1995-2004. doi: 10.1002/art.38022.
9
Performance of anti-cyclic citrullinated Peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease.抗环瓜氨酸肽检测在类风湿关节炎风险增加的受试者和已确诊疾病的受试者中的表现有所不同。
Arthritis Rheum. 2013 Sep;65(9):2243-52. doi: 10.1002/art.38017.
10
The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis.活性氧自由基和促炎细胞因子在 1 型糖尿病发病机制中的作用。
Ann N Y Acad Sci. 2013 Apr;1281(1):16-35. doi: 10.1111/j.1749-6632.2012.06826.x. Epub 2013 Jan 16.
Zotero 插件